Health Care — Acquisitions and divestitures
Business Segments · Acquisitions and divestituresAnalysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ3 2016
Last reportedQ3 2025
How to read this metric
An increase suggests active portfolio restructuring or expansion into new health categories, while a decrease indicates a focus on organic growth or a pause in M&A activity.
Detailed definition
This metric tracks the net impact of business combinations, asset purchases, and the sale of business units specifically...
Peer comparison
Comparable to 'Net M&A impact' or 'Divestiture/Acquisition revenue adjustments' reported by diversified consumer health and pharmaceutical peers.
Metric ID:
pg_segment_health_care_acquisitions_and_divestituresHistorical Data
6 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Procter & Gamble's health care — acquisitions and divestitures?
- Procter & Gamble (PG) reported health care — acquisitions and divestitures of $0.00 in Q3 2025.
- What does health care — acquisitions and divestitures mean?
- The net financial impact of buying or selling businesses within the Health Care segment.